Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma
NCT02876003
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
This study has been withdrawn prior to enrollment.
Conditions
Glioblastoma
Interventions
DRUG:
G-202
Sponsor
GenSpera, Inc.
Collaborators
[object Object]